Oncogenic mutations of ALK kinase in neuroblastoma.
D000077548:Anaplastic Lymphoma Kinase; D000818:Animals; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D002471:Cell Transformation, Neoplastic; D002889:Chromosomes, Human, Pair 2 / Q000235:genetics; D005347:Fibroblasts; D018628:Gene Dosage / Q000235:genetics; D015894:Genome, Human / Q000235:genetics; D005838:Genotype; D006801:Humans; D051379:Mice; D008969:Molecular Sequence Data; D020125:Mutation, Missense / Q000235:genetics*; D041681:NIH 3T3 Cells; D009447:Neuroblastoma / Q000201:enzymology / Q000235:genetics*; D020411:Oligonucleotide Array Sequence Analysis; D009857:Oncogenes / Q000235:genetics*; D010766:Phosphorylation; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D011505:Protein-Tyrosine Kinases / Q000172:deficiency / Q000235:genetics* / Q000378:metabolism; D034622:RNA Interference; D020794:Receptor Protein-Tyrosine Kinases; D017422:Sequence Analysis, DNA; D015398:Signal Transduction
C000626173:ALK protein, human; C000626174:Alk protein, mouse; D000077548:Anaplastic Lymphoma Kinase; D011505:Protein-Tyrosine Kinases; D020794:Receptor Protein-Tyrosine Kinases